Search Results - "Lillehaug, JR"

A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities by DUPREZ, E, BENOIT, G, FLEXOR, M, LILLEHAUG, I. R, LANOTTE, M

“…The fusion protein PML/RARA, associated with acute promyelocytic leukemia behaves as an abnormal retinoic acid (RA) receptor with altered transactivation…”
Get full text

Breast cancer prognostication and prediction in the postgenomic era by Lønning, PE, Knappskog, S, Staalesen, V, Chrisanthar, R, Lillehaug, JR

“…Expanding knowledge, together with implementation of new techniques, has fuelled the area of translational medical research aiming at improving prognostication…”
Get full text

Abstract P4-01-02: Low ATM Expression Levels Predict Resistance to Anthracyclins in TP53 and CHK2 Wild-Type Breast Tumors by Knappskog, S, Chrisanthar, R, Løkkevik, E, Anker, G, østenstad, B, Lundgren, S, Risberg, T, Mjaaland, I, Staalesen, V, Miletic, H, Leirvaag, B, Lillehaug, JR, Lønning, PE

“…Background: Mutations in TP53 and its upstream p53-activator Chk2, are known to be associated with resistance to anthracycline and mitomycin treatment in…”
Get full text

Expression of c-erbB-2 protein in papillary thyroid carcinomas by HAUGEN, D. R. F, AKSLEN, L. A, VARHAUG, J. E, LILLEHAUG, J. R

“…c-erbB-2 protein expression was investigated immunohistochemically in frozen thyroid tissue specimens from 42 patients using a polyclonal sheep antibody…”
Get full text

The Swedish Snus and the Sudanese Toombak: are they different? by Idris, A.M, Ibrahim, S.O, Vasstrand, E.N, Johannessen, A.C, Lillehaug, J.R, Magnusson, B, Wallström, M, Hirsch, J.-M, Nilsen, R

“…In Sweden, snuff (locally known as snus), was introduced since the year 1637. Presently, Sweden has the highest per capita consumption and sale figures of…”
Get full text

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB by AASLAND, R, LILLEHAUG, J. R, MALE, R, JØSENDAL, O, VARHAUG, J. E, KLEPPE, K

“…The receptor-type oncogenes c-erbB2/neu and c-erbB have been found amplified and/or overexpressed in a number of tumours of epithelial origin. We have studied…”
Get full text